AU6413996A - Mr contrast agent - Google Patents

Mr contrast agent

Info

Publication number
AU6413996A
AU6413996A AU64139/96A AU6413996A AU6413996A AU 6413996 A AU6413996 A AU 6413996A AU 64139/96 A AU64139/96 A AU 64139/96A AU 6413996 A AU6413996 A AU 6413996A AU 6413996 A AU6413996 A AU 6413996A
Authority
AU
Australia
Prior art keywords
contrast agent
contrast
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64139/96A
Inventor
Henrik S. Thomsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6413996A publication Critical patent/AU6413996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU64139/96A 1995-07-11 1996-07-10 Mr contrast agent Abandoned AU6413996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK081095A DK81095A (en) 1995-07-11 1995-07-11 Oral MR contrast agent for liver and upper intestinal tract
DK810/95 1995-07-11
PCT/DK1996/000315 WO1997002842A1 (en) 1995-07-11 1996-07-10 Mr contrast agent

Publications (1)

Publication Number Publication Date
AU6413996A true AU6413996A (en) 1997-02-10

Family

ID=8097839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64139/96A Abandoned AU6413996A (en) 1995-07-11 1996-07-10 Mr contrast agent

Country Status (6)

Country Link
US (1) US6015545A (en)
EP (2) EP1350524A1 (en)
JP (1) JP4138875B2 (en)
AU (1) AU6413996A (en)
DK (1) DK81095A (en)
WO (1) WO1997002842A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
GB9619759D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
JP2002522514A (en) * 1998-08-10 2002-07-23 ブラッコ・リサーチ・ソシエテ・アノニム Combination of positive MRI contrast agent and negative MRI contrast agent
JP2003528805A (en) * 1999-07-12 2003-09-30 ジェネンテック・インコーポレーテッド Blocking an immune response to a heterologous antigen using an antagonist that binds to CD20
AU2003210850A1 (en) 2002-02-05 2003-09-02 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
WO2003097125A2 (en) * 2002-05-17 2003-11-27 Case Western Reserve University Double contrast technique for mri-guided vascular interventions
SE527491C2 (en) 2003-12-19 2006-03-21 Cmc Contrast Ab Contraceptive composition for magnetic resonance tomography for oral administration
WO2010099804A1 (en) * 2009-03-05 2010-09-10 Cmc Contrast Ab Magnetic resonance imaging of the liver
WO2011003818A2 (en) 2009-07-06 2011-01-13 Cmc Contrast Ab Diagnostic method
US11642172B2 (en) * 2019-03-05 2023-05-09 Biosense Webster (Israel) Ltd. Showing catheter in brain
CA3140098A1 (en) * 2019-06-07 2020-12-10 Ascelia Pharma AB Compressed solid composition for mri

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3577185D1 (en) * 1984-11-01 1990-05-23 Nycomed As PARAMAGNETIC CONTRAST AGENTS FOR USE IN "IN VIVO" NMR DIAGNOSTIC METHODS AND THE PRODUCTION THEREOF.
US4863898A (en) * 1986-02-06 1989-09-05 Albion International, Inc. Amino acid chelated compositions for delivery to specific biological tissue sites
ES2007350A6 (en) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Food products enriched with nucleosides and/or nucleotides and preparation thereof.
NO884225L (en) * 1987-09-25 1989-03-28 Salutar Inc NMR IMAGING MN (II) - COORDINATION RELATIONS.
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US4889931A (en) * 1988-09-27 1989-12-26 Salutar, Inc. Manganese (II) chelate manufacture
US5064636A (en) * 1989-10-19 1991-11-12 Li King C P Paramagnetic oil emulsions as enteric MRI contrast agents
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US5215750A (en) * 1991-09-04 1993-06-01 Keane Ii Michael A L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control
JP2911674B2 (en) * 1992-02-20 1999-06-23 明治乳業株式会社 Gastrointestinal imaging composition
US5292729A (en) * 1992-08-14 1994-03-08 Albion International, Inc. II-bond aromatic vitamin chelates
US5422127A (en) * 1992-12-21 1995-06-06 Bristol-Myers Squibb Company Nutritional compositions containing vitamin D esters
US5340603A (en) * 1993-08-30 1994-08-23 Abbott Laboratories Nutritional product for human infants having chronic lung disease
IT1265440B1 (en) * 1993-12-24 1996-11-22 Bracco Spa PARAMAGNETIC DIAGNOSTIC FORMULATIONS AND METHOD OF USE OF THEM
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions

Also Published As

Publication number Publication date
EP1350524A1 (en) 2003-10-08
US6015545A (en) 2000-01-18
JP4138875B2 (en) 2008-08-27
WO1997002842A1 (en) 1997-01-30
JPH11508594A (en) 1999-07-27
EP0839057A1 (en) 1998-05-06
DK81095A (en) 1997-01-12

Similar Documents

Publication Publication Date Title
AU2263295A (en) Contrast agents
AU2916695A (en) Localizer
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU2784397A (en) Contrast agents
AU1030997A (en) Taphane
AU5539596A (en) Anti-obesity agents
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU6413996A (en) Mr contrast agent
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU3554995A (en) Antipicornaviral agents
AU6473396A (en) Finishing agent
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU6544294A (en) Polystyrene-dissolving agent
AU6473496A (en) Retention agent
AU5108596A (en) Morphine-3-esters
AU7287596A (en) Strengthening agent
AU1615995A (en) Instrument comprising seat
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU6369996A (en) Anti-piroplasmotic agent
AU2161897A (en) Helicopter-airplane